Search
Displaying all 5 results
Ublituximab
go.drugbank.com/drugs/DB11850
ApprovedInvestigational
CD20, an antigen expressed by various B and T cells, is an attractive therapeutic target in various cancers and autoimmune conditions. Monoclonal antibodies for B cell depletion rely on their binding affinity and ability to clear bound cells through mechanisms such as antibody-dependent cellular cytotoxicity (ADCC),...
Clinically Isolated Syndrome
go.drugbank.com/conditions/DBCOND0033497Drugs: Dimethyl fumarate · Diroximel fumarate · Glatiramer · Ocrelizumab · Ofatumumab · Ozanimod +1 moreActive Secondary Progressive Multiple Sclerosis (SPMS)
go.drugbank.com/conditions/DBCOND0131872Drugs: Dimethyl fumarate · Diroximel fumarate · Glatiramer · Ocrelizumab · Ofatumumab · Ozanimod +2 moreRelapsing Multiple Sclerosis (RMS)
go.drugbank.com/conditions/DBCOND0044896Drugs: Cladribine · Daclizumab · Fingolimod · Interferon beta-1a · Interferon beta-1b · Ocrelizumab +5 moreRelapsing Remitting Multiple Sclerosis (RRMS)
go.drugbank.com/conditions/DBCOND0036413Drugs: Alemtuzumab · Dimethyl fumarate · Diroximel fumarate · Glatiramer · Human interferon beta · Mitoxantrone +6 more